Resection for Multiple Hepatocellular Carcinomas (HCC)
Hepatic Resection for Multiple Hepatocellular Carcinoma on Cirrhosis
1 other identifier
interventional
87
1 country
1
Brief Summary
Surgical resection in patients with multiple hepatocellular carcinomas (HCC) remains controversial. The aim of this study was to investigate the outcome of a consecutive cohort of patients resected for multiple HCC, without macrovascular invasion, in order to identify clinically reliable parameters to select patients for surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hepatocellular-carcinoma
Started Jun 2001
Longer than P75 for not_applicable hepatocellular-carcinoma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
June 29, 2011
CompletedFirst Posted
Study publicly available on registry
July 4, 2011
CompletedSeptember 20, 2011
September 1, 2011
10 years
June 29, 2011
September 18, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Overall survival plus multivariate analysis
The primary endpoint of the study was the overall survival of patients resected for multiple HCC, and the univariate and multivariate analyses of prognostic factors for overall survival.
10 years
Secondary Outcomes (1)
Disease-free survival
10 years
Study Arms (1)
hepatic resection
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- patients with multiple HCC without macrovascular invasion on liver cirrhosis
You may not qualify if:
- macrovascular invasion;
- normal liver;
- distant or lymphnodes metastasis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Milan IRCCS Istituto Clinico Humanitas
Rozzano, Milan, MI, 20089, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Guido Torzilli, MD, PhD
University of Milan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Surgery
Study Record Dates
First Submitted
June 29, 2011
First Posted
July 4, 2011
Study Start
June 1, 2001
Primary Completion
June 1, 2011
Study Completion
June 1, 2011
Last Updated
September 20, 2011
Record last verified: 2011-09